Home / Members / Fabio Martinelli

Fabio Martinelli

Assistant Professor

Obstetrics and Gynecology
Assistant Professor

Education

  • Jul 2007–Jul 2012 Residency Program in Obstetrics and Gynecology -70/70 cum laude –  Università degli Studi of Milan
  • Apr 2011– Oct 2011 Visiting Research Fellow at The University of Texas MD Anderson Cancer Center – Gynecologic Oncology and Reproductive Medicine Department – Huston (TX), USA
  • Jul 2006 Medical Doctor – 110/110 cum  laude – Università degli Studi of Milan (Italy)
  • Feb 2005–Jun 2005 SOCRATES/ERASMUS Project – Universidad Autonoma de Madrid – Facultad de Medicina y Cirugia

Academic background

  • Current role – Assistant Professor of Gynecology and Obstetrics (tenure track – RTT)
  • Jul 2020 National Scientific Qualification for Associate and Full Professorship in Gynecology and Obstetrics – Ministry of Education, University and Research: Italy
  • Jan 2016 – Dec 2018 European Society of Gynaecological Oncology (ESGO)  Training Fellowship at Fondazione IRCCS Istituto Nazionale per lo Studio e la Cura dei Tumori – Milan ESGO certification as an accreditated European Gynaecological Oncologist
  • Feb 2017 – Jun 2017 Faculty at university specialization course “Linfologia Clinica” – Università degli Studi di Milano
  • Aug 2012 – Jul 2013 Research Assignment: “Predittori Biologici di Risposta alla Chemioterapia nel Ca della Cervice Uterina” – Gynecologic Oncology Dept – Fondazione IRCCS Istituto Nazionale per lo Studio e la Cura dei Tumori – Milan
  • Apr 2011 – Oct 2011 Visiting Research Fellow at The University of Texas MD Anderson Cancer Center – Gynecologic Oncology and Reproductive Medicine Department – Huston (TX), USA

Membership and leadership roles

  • European Commission Funding & Tenders – Expert Evaluator EX2021D431400 since 2021
  • EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY – Expert in Medical Devices since 2021
  • EURACAN – European Reference Networks (ERN) for Rare and Low Prevalence Complex Diseases (European commission) European Reference Networks – the ERN for all rare adult solid cancers – member since 2022
  • Internal Review Board (IRB) Fondazione IRCCS Istituto Nazionale per lo Studio e la Cura dei Tumori – Milan – Expert component since  2024
  • European Nework of Young Gynaecologic Oncologists (ENYGO) National Representative (NATREP) of Italy 2021-2023
  • Associate Editor e Topic Editor in Women’s Cancer/Gynecological Oncology – Frontiers in Oncology since 2018
  • Editorial Board Member. Experimental and Therapeutic Medicine
  • Editorial Board Member. International Journal of Gynecological Cancer
  • Società Italiana di Oncologia Ginecologica (SIOG) –Board Member since 2015
  • McMaster Online Rating of Evidence (MORE), McMaster University – Canada – Rater since 2017
  • AAGL’s Oncology Special Interest Group – member since 2011
  • European Society of Gynaecological Oncology (ESGO) – member since 2020
  • Principal Investigator at INT-Milan: “Patient Outcomes following Interval and Delayed Cytoreductive Surgery in Advanced Ovarian Cancer: a GO SOAR led Study (GO SOAR2)”. Coordinating Center Centre team based at NHS Grampian, UK, protocol INT 11-23
  • Principal Investigator at INT-Milan: “Determining Post-Operative Morbidity & Mortality Following Gynaecological Oncology Surgery: a Multicentre, International, Prospective Cohort Study Led by the Global Gynaecological Oncology Surgical Outcomes Collaborative (GO SOAR)”. Coordinating Center Centre team based at NHS Grampian, UK, protocol INT 46-21
  • Principal Investigator at INT-Milan: “Cytoreductive Surgery in Advanced Endometrial Cancer. Multicenter Retrospective Study.” Coordinatig center: ISTITUTO NAZIONALE TUMORI NAPOLI, protocol INT 95-20
  • Principal Investigator and Study coordinator of a multicenter study ““The role of micrometastasis and isolated tumor cells (ITCs) in uterine cancers (endometrial/cervical) submitted to sentinel lymph nodes (SLN) procedure: an observational study” Coordinating Center Fondazione IRCCS Istituto Nazionale Tumori – Milano Protocol INT 135-19v2.0  NCT04403867
  • Principal Investigator ““The role of micrometastasis and isolated tumor cells (ITCs) in uterine cancers (endometrial/cervical) submitted to sentinel lymph nodes (SLN) procedure: an observational study” Fondazione IRCCS Istituto Nazionale Tumori – Milano Protocol INT 135-19
  • Principal Investigator at INT-Milan: “Radical Abdominal Hysterectomy vs Laparoscopic Radical Hysterectomy in cervical cancer stage IA1-IB1: Does tumor size matter? A Multicenter Cohort study.” Coordianting center: Instituto Nacional de Cancerología (INC) Colombia, protocol INT 61-19

Grants and awards

  • International Journal of Gynecological Cancer (IJGC) Top Editorial Board Member Award 2021
  • International Journal of Gynecological Cancer (IJGC) Top Reviewer Award 2020
  • Publons Top Peer Reviewer – Clinical Medicine 2019
  • Publons Top Peer Reviewer – Cross Fields 2019
  • Publons Peer Review Award 2018
  • Lega Italiana per la Lotta contro i Tumori – Mantova, borsa di studio 2007
HUMANITAS GROUP

Humanitas is a highly specialized Hospital, Research and Teaching Center. Built around centers for the prevention and treatment of cancer, cardiovascular, neurological and orthopedic disease – together with an Ophthalmic Center and a Fertility Center – Humanitas also operates a highly specialised Emergency Department.